tiprankstipranks
Advertisement
Advertisement
Myles Minter Reiterates Hold on Alector as Late-Stage Trial Failures Trigger Pipeline Reset but Next-Gen Brain Carrier Platform Offers Long-Term Optionality
PremiumRatingsMyles Minter Reiterates Hold on Alector as Late-Stage Trial Failures Trigger Pipeline Reset but Next-Gen Brain Carrier Platform Offers Long-Term Optionality
3M ago
Alector Establishes $125 Million At-the-Market Offering
Premium
Company Announcements
Alector Establishes $125 Million At-the-Market Offering
3M ago
Alector reports Q1 EPS (21c), consensus (28c)
Premium
The Fly
Alector reports Q1 EPS (21c), consensus (28c)
3M ago
BTIG upgrades Alector to Buy on shift to novel therapeutics
PremiumThe FlyBTIG upgrades Alector to Buy on shift to novel therapeutics
5M ago
Alector upgraded to Buy from Neutral at BTIG
Premium
The Fly
Alector upgraded to Buy from Neutral at BTIG
5M ago
Buy Rating on Alector: Strategic Pivot to Blood–Brain-Barrier Platform and Emerging Alzheimer’s Assets AL137 and AL064 Underpins Attractive Risk–Reward
Premium
Ratings
Buy Rating on Alector: Strategic Pivot to Blood–Brain-Barrier Platform and Emerging Alzheimer’s Assets AL137 and AL064 Underpins Attractive Risk–Reward
6M ago
Alector Appoints Neil Berkley as CFO
PremiumCompany AnnouncementsAlector Appoints Neil Berkley as CFO
8M ago
Alector names Neil Berkley as CFO, Chief Business Officer
Premium
The Fly
Alector names Neil Berkley as CFO, Chief Business Officer
8M ago
Cautious Outlook for Alector: Uncertainties in Clinical Validation and Financial Concerns Lead to Sell Rating
Premium
Ratings
Cautious Outlook for Alector: Uncertainties in Clinical Validation and Financial Concerns Lead to Sell Rating
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100